The market for infection surveillance solutions, indispensable tools that aid healthcare professionals in data gathering, analysis, and interpretation related to patient infections, is projected to experience substantial growth, according to a study by InsightAce Analytic Pvt. Ltd. Valued at US$ 544.93mm in 2022, the market is expected to burgeon to US$ 1581.37mn by 2031, with a CAGR of 12.7% during 2024 to 2031.
Infection surveillance solutions provide real-time information to medical practitioners, ensuring rapid and targeted responses to ailment management. These solutions play a pivotal role in the diagnosis and management of antibiotic-resistant organisms and the prevention of several hospital-acquired diseases like pneumonia resulting from ventilator usage, urinary tract, surgical wounds, and central-line bloodstream infections.
The rise in hospital-acquired infections (HAIs), primarily due to unsanitary practices and an element of negligence in healthcare facilities, is a major factor spearheading this market’s expansion. The advent of new IT systems to maintain electronic healthcare records and the rising healthcare costs have thrust infection surveillance solutions into the limelight.
The market is filled with prominent players one of the driving factors is the increasing prevalence of HAIs worldwide. Subdued immune responses in patients, decline in the efficacy of medicinal procedures, rising healthcare expenditure, and inadequate hygiene practices have contributed to the tendency of HAIs, ranking high amongst the leading causes of fatalities in healthcare facilities.
The shift towards the automation of healthcare facilities and the surge in demand for web-based and mobile platforms represent other key trends in this market. However, the market expansion may be hampered due to resistance amongst medical practitioners towards the acceptance of innovative healthcare products, high cost of the software solutions and the lack of skilled professionals. Nonetheless, customer preferences for automated healthcare facilities and an increasing demand for web-based platforms are likely to provide the counter-push for growth in this sector.
Regionally, North America is expected to dominate the infection surveillance solutions market, largely because of the increasing efforts for controlling HAIs and the expansion of healthcare institutions. Cutting-edge on-premise and web-based software solutions provided by key vendors drive the regional market growth. With a burgeoning health insurance sector, increased healthcare expenditure, and rising prevalence of HAIs, Asia Pacific region too will witness healthy growth rates in the near future. The study by InsightAce Analytic also unveiled the segmentation of the infection surveillance solutions market by product and services, end-users, and regions.